127 related articles for article (PubMed ID: 11145513)
41. Resolution of treatment-related arthralgias and serologic findings with a switch of TNF antagonist therapies in a patient with psoriatic arthritis.
Fischer P
J Clin Rheumatol; 2007 Oct; 13(5):294-5. PubMed ID: 17921804
[No Abstract] [Full Text] [Related]
42. Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis.
Capo A; Di Nicola M; Auriemma M; Piaserico S; Cuccurullo C; Santilli F; Davi G; Amerio P
Eur J Dermatol; 2014; 24(1):133-5. PubMed ID: 24589526
[No Abstract] [Full Text] [Related]
43. Etanercept: An overview.
Goffe B; Cather JC
J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S105-11. PubMed ID: 12894133
[TBL] [Abstract][Full Text] [Related]
44. Etanercept: a new era in the treatment of psoriatic arthritis.
Mease PJ
Am J Manag Care; 2002 Apr; 8(6 Suppl):S181-93. PubMed ID: 11990863
[TBL] [Abstract][Full Text] [Related]
45. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis.
Spadaro A; Ceccarelli F; Scrivo R; Valesini G
Ann Rheum Dis; 2008 Nov; 67(11):1650-1. PubMed ID: 18854519
[No Abstract] [Full Text] [Related]
46. Case of coexisting psoriatic arthritis and bullous pemphigoid improved by etanercept.
Nin M; Tokunaga D; Ishii N; Komai A; Hashimoto T; Katoh N
J Dermatol; 2013 Jan; 40(1):55-6. PubMed ID: 22963138
[No Abstract] [Full Text] [Related]
47. Assessing the value of rheumatoid arthritis treatment alternatives: the potential effect of tumor necrosis factor inhibitors.
Mizutani W
Manag Care Interface; 2003 Mar; 16(3):44-50, 55. PubMed ID: 12715413
[TBL] [Abstract][Full Text] [Related]
48. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
[No Abstract] [Full Text] [Related]
49. Efficacy of adalimumab, etanercept, and infliximab in psoriatic arthritis based on ACR50 response after 24 weeks of treatment.
Brodszky V; Pentek M; Gulacsi L
Scand J Rheumatol; 2008; 37(5):399-400. PubMed ID: 18821278
[No Abstract] [Full Text] [Related]
50. Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept.
Moustou AE; Stratigos AJ; Vergou T; Gregoriou S; Georgala S; Danopoulou I
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):968-9. PubMed ID: 19207660
[No Abstract] [Full Text] [Related]
51. Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings.
Bonafede M; Fox KM; Watson C; Princic N; Gandra SR
Adv Ther; 2012 Aug; 29(8):664-74. PubMed ID: 22886712
[TBL] [Abstract][Full Text] [Related]
52. Use of etanercept in children.
Wargula JC; Lovell DJ
Bull Rheum Dis; 2000; 49(12):1-4. PubMed ID: 11314579
[No Abstract] [Full Text] [Related]
53. Psoriatic arthritis in a military aviator.
Sulit DJ; Clarke JE
Aviat Space Environ Med; 2005 Jul; 76(7):684-8. PubMed ID: 16018354
[TBL] [Abstract][Full Text] [Related]
54. Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection.
Rokhsar C; Rabhan N; Cohen SR
J Am Acad Dermatol; 2006 Feb; 54(2):361-2. PubMed ID: 16443079
[No Abstract] [Full Text] [Related]
55. [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society].
Salvarani C; Olivieri I; Cantini F; Marchesoni A; Punzi L; Scarpa R; Matucci-Cerinic M
Reumatismo; 2004; 56(3):133-4, 136-8. PubMed ID: 15470517
[No Abstract] [Full Text] [Related]
56. Dramatic repair of joint damage in psoriatic arthritis.
van der Heijde D; Landewé RB
J Rheumatol; 2011 Jun; 38(6):969-70. PubMed ID: 21632684
[No Abstract] [Full Text] [Related]
57. Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis.
Kowalzick L; Bertolini J; Baumann C; Walther B; Truhm B; Eickenscheidt L
J Dtsch Dermatol Ges; 2013 May; 11(5):447-9. PubMed ID: 23343137
[No Abstract] [Full Text] [Related]
58. Psoriatic arthritis: radiographic joint repair following etanercept therapy.
Garcia-Valladares I; Cuchacovich R; Espinoza LR
J Rheumatol; 2012 Jan; 39(1):185; author reply 186. PubMed ID: 22210679
[No Abstract] [Full Text] [Related]
59. Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review.
De Angelis F; Di Rocco A; Minotti C; Valesini G; Cartoni C; Riminucci M; Conti F; Finolezzi E; Armiento D; Grammatico S; Massaro L; Fama A; Colafigli G; Viccarone C; Foà R; Martelli M
Leuk Res; 2012 Sep; 36(9):e199-201. PubMed ID: 22749557
[No Abstract] [Full Text] [Related]
60. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.
Heiberg MS; Koldingsnes W; Mikkelsen K; Rødevand E; Kaufmann C; Mowinckel P; Kvien TK
Arthritis Rheum; 2008 Feb; 59(2):234-40. PubMed ID: 18240258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
